Table 3 Mean dose and usage of cinacalcet Twenty-three participants were receiving cinacalcet on at least one study visit. Mean dose includes only those participants receiving cinacalcet at that visit. Overall mean difference includes all 23 participants and all visits
Standard | Extended | Between-Group difference | ||||
|---|---|---|---|---|---|---|
N/11 | Mean dose (SD) | N/12 | Mean (sd) | Mean difference (95% CI) | P-value | |
Baseline | 4 | 50.0 (14.1) | 7 | 51.4 (56.7) | 1.4 (−65.2, 68.1) | |
3-month | 8 | 43.1 (15.8) | 7 | 34.3 (11.3) | −8.8 (−24.4, 6.7) | |
6-month | 9 | 41.7 (15.4) | 6 | 35.0 (12.3) | −6.7 (−22.9, 9.6) | |
9-month | 10 | 42.5 (14.8) | 6 | 48.3 (36.0) | 5.8 (−21.4, 33.0) | |
12-month | 8 | 46.9 (15.8) | 7 | 30.3 (11.0) | −16.6 (−32.0, −1.2) | |
Overall mean difference | − 11.7 (−29.0, 5.9) | 0.19 | ||||